Ovarian Cancer Survival Increased 5 Months Overall With Beta Blockers – Study – The Speaker | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Advertisements

Feeds:: Posts; Comments

« Why Does Cytotoxic Chemotherapy Still Remain a Mainstay in Many Chemotherapeutic Regimens?

Development of Chemoresistance to Targeted Therapies: Alterations of Cell Signaling & the Kinome »

Ovarian Cancer Survival Increased 5 Months Overall With Beta Blockers – Study – The Speaker

September 16, 2015 by 2012pharmaceutical

Overall survival for epithelial ovarian cancer (EOC) patients is prolonged approximately 5 months as a result of treatment with beta blockers, a type …

Sourced through Scoop.it from: thespeaker.co

See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY

Advertisements

Posted in Uncategorized | 3 Comments

3 Responses

on September 17, 2015 at 2:35 AM | Reply creativebiolabs

I was wondering whether there are more reliable evidences about the cancer survival.
on September 17, 2015 at 10:39 AM | Reply lbretes

I think that this amazing, and medical oncologists must know about this new utility of old drugs(cheaper that MABs).Sometimes the clinitian prescribes this drug in another setting in these patiens(cardiovascular) and benefit the cancer patient……………..
on September 17, 2015 at 11:17 AM | Reply sjwilliamspa

I will later in the week provide a curation of the history of the rationale for this study. It starts with microarray experiments done in the late 90’s.

Leave a Reply to creativebiolabs Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Google account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s

%d bloggers like this: